| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...865138G |
| P356 | DOI | 10.1371/JOURNAL.PONE.0065138 |
| P932 | PMC publication ID | 3672200 |
| P698 | PubMed publication ID | 23750239 |
| P5875 | ResearchGate publication ID | 237093601 |
| P2093 | author name string | Min Liu | |
| Jie Gao | |||
| Hailin Tang | |||
| Minqing Wu | |||
| Xiaoming Xie | |||
| Xinhua Xie | |||
| Jiaoli Guo | |||
| Laisheng Li | |||
| P2860 | cites work | MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 |
| Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells | Q24651034 | ||
| mir-29 regulates Mcl-1 protein expression and apoptosis | Q24652606 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| The functions of animal microRNAs | Q27860621 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis | Q28269041 | ||
| Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer | Q28295895 | ||
| MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2 | Q28302211 | ||
| A perspective on cancer cell metastasis | Q28307891 | ||
| The BCL-2 protein family: opposing activities that mediate cell death | Q29547380 | ||
| MicroRNAs as oncogenes and tumor suppressors | Q81406722 | ||
| Endogenous human microRNAs that suppress breast cancer metastasis | Q29617352 | ||
| Tumor metastasis: mechanistic insights and clinical challenges | Q29617676 | ||
| A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). | Q31016573 | ||
| MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer | Q33668463 | ||
| Targeting microRNAs in cancer: rationale, strategies and challenges | Q34141089 | ||
| Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone | Q34274930 | ||
| Transcription and processing of human microRNA precursors | Q34378218 | ||
| MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. | Q34442762 | ||
| MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1. | Q34446981 | ||
| Serum microRNA-155 as a potential biomarker to track disease in breast cancer | Q34447755 | ||
| Global cancer statistics in the year 2000. | Q34571897 | ||
| Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth | Q35029501 | ||
| Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy | Q35039281 | ||
| Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters | Q35721994 | ||
| Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion | Q36460483 | ||
| miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo | Q36610611 | ||
| Implications of micro-RNA profiling for cancer diagnosis. | Q36617827 | ||
| MicroRNAs and their regulatory roles in animals and plants | Q36649761 | ||
| Role of miRNA in carcinogenesis and biomarker selection: a methodological view | Q36950439 | ||
| Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening | Q37708994 | ||
| The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells. | Q39273352 | ||
| MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. | Q39299200 | ||
| MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. | Q39309630 | ||
| MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1. | Q39343253 | ||
| Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1. | Q39467363 | ||
| Development of microRNA-145 for therapeutic application in breast cancer | Q39514100 | ||
| miR-181a and miR-630 regulate cisplatin-induced cancer cell death | Q39741509 | ||
| Repressing the repressor: a new mode of MYC action in lymphomagenesis | Q39886881 | ||
| Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases | Q40602663 | ||
| MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms | Q42945633 | ||
| MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy | Q45358834 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | e65138 | |
| P577 | publication date | 2013-06-04 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1 | |
| P478 | volume | 8 |
| Q89777029 | An aptamer-based targeted delivery of miR-26a protects mice against chemotherapy toxicity while suppressing tumor growth |
| Q89509558 | Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression |
| Q47571295 | Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model. |
| Q28072414 | ApoptomiRs of Breast Cancer: Basics to Clinics |
| Q35122880 | BikDDA, a mutant of Bik with longer half-life expression protein, can be a novel therapeutic gene for triple-negative breast cancer |
| Q92286877 | Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer |
| Q36702439 | Comparative transcriptome profiling of the injured zebrafish and mouse hearts identifies miRNA-dependent repair pathways |
| Q37431423 | Disturbing miR-182 and -381 inhibits BRD7 transcription and glioma growth by directly targeting LRRC4. |
| Q38789206 | Downregulated microRNA-26a modulates prostate cancer cell proliferation and apoptosis by targeting COX-2 |
| Q34240895 | Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events |
| Q34358599 | Expression profiling of exosomal miRNAs derived from human esophageal cancer cells by Solexa high-throughput sequencing |
| Q39008544 | Functional analysis of miR-101-3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis |
| Q46317673 | Förster resonance energy transfer to impart signal-on and -off capabilities in a single microRNA biosensor |
| Q91529114 | HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells |
| Q36733776 | Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia |
| Q37437619 | Identification of associations between small molecule drugs and miRNAs based on functional similarity |
| Q54989577 | Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers. |
| Q37600040 | Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells |
| Q61800908 | Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology |
| Q64071558 | LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis |
| Q38736898 | Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. |
| Q38828580 | MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2 |
| Q90405854 | MiR-26a inhibits thyroid cancer cell proliferation by targeting ARPP19 |
| Q36391854 | MiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC. |
| Q46121766 | MiR-98 is involved in rat embryo implantation by targeting Bcl-xl |
| Q35955244 | MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cells |
| Q36299580 | MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer |
| Q34227586 | MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells |
| Q39012739 | MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer |
| Q33989118 | MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China |
| Q49790324 | MicroRNA-26a and Tumor |
| Q41856145 | MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1. |
| Q33886196 | MicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on MITF gene |
| Q54094778 | MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer. |
| Q36847079 | MicroRNAs in Hyperglycemia Induced Endothelial Cell Dysfunction |
| Q28081081 | MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential |
| Q57118829 | MicroRNAs mediate therapeutic and preventive effects of natural agents in breast cancer |
| Q33643578 | Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer |
| Q95265798 | Mir-30b-5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2 |
| Q47373137 | Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion. |
| Q35092068 | Next-generation sequencing identifies deregulation of microRNAs involved in both innate and adaptive immune response in ALK+ ALCL. |
| Q37210093 | The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer |
| Q40283637 | The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis |
| Q49723864 | The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase. |
| Q38796729 | The role of microRNA-26a in human cancer progression and clinical application |
| Q38221040 | The role of microRNAs in human breast cancer progression |
| Q47701015 | Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease |
| Q42786047 | Tumor Protein p63/microRNA Network in Epithelial Cancer Cells |
| Q37288437 | miR-101 inhibits glioma cell invasion via the downregulation of COX-2. |
| Q42735024 | miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer |
| Q37564535 | miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13. |
| Q92761624 | miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2 |
| Q39338208 | miR-3940-5p Functions as a Tumor Suppressor in Non-Small Cell Lung Cancer Cells by Targeting Cyclin D1 and Ubiquitin Specific Peptidase-28. |
| Q98291912 | miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer |
| Q92069867 | microRNA regulators of apoptosis in cancer |
| Q38336073 | microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer |
Search more.